Cameron Health
Develops S-ICD system, a subcutaneous implantable defibrillator that provides protection from sudden cardiac arrest.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
| investor investor investor | €0.0 | round | |
| investor investor investor | €0.0 | round | |
| investor investor investor investor | €0.0 | round | |
| investor investor investor investor investor investor | €0.0 | round | |
| investor investor investor | €0.0 | round | |
$1.4b Valuation: $1.4b | Acquisition | ||
| Total Funding | 000k | ||
Related Content
Cameron Health, a subsidiary of Boston Scientific, specializes in developing innovative medical devices aimed at improving patient health outcomes. The company operates within the healthcare sector, focusing on cardiovascular, gastroenterology, and urology specialties. Cameron Health serves a diverse range of clients, including hospitals, clinics, and healthcare professionals globally. The business model revolves around the research, development, and commercialization of advanced medical technologies. Revenue is generated through the sale of these medical devices and related services. The company is committed to sustainability and corporate responsibility, ensuring that its operations positively impact communities worldwide.
Keywords: medical devices, cardiovascular, gastroenterology, urology, healthcare, innovation, patient health, sustainability, corporate responsibility, global.